Skip to content

Medical-device intelligence

Terumo Cardiovascular Systems Corporation: FDA clearances and recalls

Research Terumo Cardiovascular Systems Corporation in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

29 clearance records and 358 recall records in the covered releases, across 1 source company names and 26 product codes. Dated history runs from Sep 19, 2002 to May 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

387 matching records
Device / recordCompany in FDA recordSourceSource date
Sarns Modular Perfusion System 8000 base, 4 pump 220/240V. The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on t…Z-2046-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 8000 base, 5 pump 220/240V. The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on t…Z-2047-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 8000 base, 4 pump 100V. The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on the e…Z-2048-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 8000 base, 5 pump 100V. he Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on the ex…Z-2049-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 9000, 115V with color screen. The Sarns Perfusion System 9000 is indicated for use as a heart-lung system for p…Z-2050-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 9000, 220/240V with color screen. The Sarns Perfusion System 9000 is indicated for use as a heart-lung system f…Z-2051-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 9000, 100V with color screen. The Sarns Perfusion System 9000 is indicated for use as a heart-lung system for p…Z-2052-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
System 1 Base, 100/120V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bl…Z-2020-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 17, 2012FDA classification date
System 1 Base, 220/240V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bl…Z-2021-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 17, 2012FDA classification date
Terumo Advanced Perfusion System 1 System 1 Base, 100/120V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours o…Z-2009-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 13, 2012FDA classification date
Terumo Advanced Perfusion System 1 System 1 Base, 220/240V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours o…Z-2010-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 13, 2012FDA classification date
Terumo Advanced Perfusion System 1 Electronic O2 Blender/Analyzer. The electronic gas blender provides control and monitoring of the gas flow…Z-1962-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
Terumo Advanced Perfusion System 1 System 1 Base, 100/120V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours o…Z-1963-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
Terumo Advanced Perfusion System 1 System 1 Base, 220/240 V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours …Z-1964-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base, 100/120V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours in the extracorporeal circulation of bl…Z-1965-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base, 220/240V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-1966-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base 100/120V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-1968-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base 220/240V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-1969-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base 100/120V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-1970-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
System 1 Base 220/240V. The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of blo…Z-1971-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 9, 2012FDA classification date
Central Control Module for System 1: System 1 Base, 100/120V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on …Z-1957-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 6, 2012FDA classification date
Central Control Module for System 1: System 1 Base, 220/240V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on …Z-1958-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 6, 2012FDA classification date
Sarns Antegrade Cardioplegia Cannula: ROOT INFUSTION VENT CATHETER WITH 12 GAUGE BLUE NEEDLE RECTANGULAR FLANGE, 6" (15 CM) LONG Product Usage…Z-1875-2012 · DWFTerumo Cardiovascular Systems CorporationRecallJun 27, 2012FDA classification date
SARNS ANTEGRADE: CARDIOPLEGIA CANNULA: ROOT INFUSION VENT/CATHETER WITH 14- GAUGE WHITE NEEDLE, RECTANGULAR FLANGE, 6" (15 CM) LONG Product Us…Z-1876-2012 · DWFTerumo Cardiovascular Systems CorporationRecallJun 27, 2012FDA classification date
SARNS ANTEGRADE CARDIOPLEGIA CANNULA: ROOT INFUSION CANNULA WITH 14-GAUGE WHITE NEEDLE,RECTANGULAR FLANGE AND SUTURE COLLAR, 6" (15CM) LONG Pr…Z-1877-2012 · DWFTerumo Cardiovascular Systems CorporationRecallJun 27, 2012FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗